Ablynx secures FDA approval for Cablivi to treat aTTP

In a significant milestone for Belgian biopharma company Ablynx, the U.S. Food and Drug Administration (FDA) has granted approval for Cablivi (caplacizumab-yhdp), a nanobody designed ... Read More